Stay updated on Satralizumab in Generalized Myasthenia Gravis Clinical Trial
Sign up to get notified when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.

Latest updates to the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the Study Details page, indicating a content update. This appears to be a minor metadata change with no evident alterations to trial data or eligibility criteria.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe Taiwan study site entry is updated from 'Taoyuan, Taiwan, 333' to 'Taoyuan City, Taiwan, 333' to reflect the correct city designation.SummaryDifference0.0%

- Check35 days agoChange DetectedThe page footer has been updated to reflect a new ClinicalTrials.gov release revision (v3.5.3 instead of v3.5.2).SummaryDifference0.0%

- Check42 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check71 days agoChange DetectedThe Italy location entry was updated from Napoli, Campania, 80131 to Naples, Campania, 80131. The page revision label changed from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing Revision: v3.4.2. This appears to be a small administrative update with no changes to study details.SummaryDifference0.0%

Stay in the know with updates to Satralizumab in Generalized Myasthenia Gravis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.